FK317, a Novel Substituted Dihydrobenzoxazine, Exhibits Potent Antitumor Activity against Human Tumor Xenografts in Nude Mice

Search this Article

Author(s)

    • NAOE Yoshinori
    • Department of Pharmacology, Pharmacological Research Laboratories,Fujisawa Pharmaceutical Co., Ltd.
    • INAMI Masamichi
    • Department of Pharmacology, Pharmacological Research Laboratories,Fujisawa Pharmaceutical Co., Ltd.
    • MATSUMOTO Sanae
    • Department of Pharmacology, Pharmacological Research Laboratories,Fujisawa Pharmaceutical Co., Ltd.
    • TAKAGAKI Shoji
    • Biopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
    • FUJIWARA Tomoichi
    • Biopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
    • YAMAZAKI Sachiko
    • Biopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
    • KAWAMURA Ikuo
    • Department of Pharmacology, Pharmacological Research Laboratories,Fujisawa Pharmaceutical Co., Ltd.
    • NISHIGAKI Fusako
    • Department of Pharmacology, Pharmacological Research Laboratories,Fujisawa Pharmaceutical Co., Ltd.
    • TSUJIMOTO Susumu
    • Department of Pharmacology, Pharmacological Research Laboratories,Fujisawa Pharmaceutical Co., Ltd.
    • MANDA Toshitaka
    • Department of Pharmacology, Pharmacological Research Laboratories,Fujisawa Pharmaceutical Co., Ltd.
    • SHIMOMURA Kyoichi
    • Department of Pharmacology, Pharmacological Research Laboratories,Fujisawa Pharmaceutical Co., Ltd.

Journal

  • Jpn. J. Cancer Res

    Jpn. J. Cancer Res 89(12), 1306-1317, 1998-12-30

References:  28

Cited by:  1

Codes

  • NII Article ID (NAID)
    10008088030
  • NII NACSIS-CAT ID (NCID)
    AA00690844
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    09105050
  • Data Source
    CJP  CJPref 
Page Top